Atorvastatin Calcium
Product Images NDC 45865-743

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 45865-743). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (743)

Pdp (743)
This is a description of Atorvastatin Calcium Tablets that contains 10mg of medication. It is a generic version of the medication Lipitor. The text includes a number, which is likely a reference or identification number.*
FDA Label Image

Chemical Structure (Atorvastatin Calcium Tablets 1)

FDA Label Image

Figure 1 (Atorvastatin Calcium Tablets 2)

Figure 1 (Atorvastatin Calcium Tablets 2)
The available text provides a graph showing the cumulative incidence of a condition over a period of 35 years. The percentage values at 10-year intervals are 15%, 30%, and 404%. An HR (hazard ratio) of 0.64 with a confidence interval of 0.50-0.83 and a p-value of 0.0005 is also presented. The description suggests that this is a medical study evaluating the incidence of a certain condition over time.*
FDA Label Image

Figure 2 (Atorvastatin Calcium Tablets 3)

Figure 2 (Atorvastatin Calcium Tablets 3)
This is a description of a study outcome on time to the first primary endpoint in a cohort that was followed up for four years. The cumulative hazard rates (%) at years 1, 2, 3, 4, and HR with 95% confidence interval and p-value are provided. However, no information on the study design or primary endpoint is available.*
FDA Label Image

Figure 3 (Atorvastatin Calcium Tablets 4)

Figure 3 (Atorvastatin Calcium Tablets 4)
This is a table that displays the percentage of subjects who experienced a major cardiovascular event while taking either Atorvastatin 10 mg or Atorvastatin 80 mg. There is also information on the hazard ratio and the time to the first major cardiovascular endpoint.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.